OrcaSonics Innovation

The Solution

The Solution: EchoWear

🫀

Continuous Monitoring

Continuous cardiac pump function monitoring 24/7

📡

Direct Measurement

Direct measurement of ejection fraction and cardiac output

⚠️

Early Warning

7–14 days advance warning before symptoms appear

🩹

Non-Invasive

Non-invasive external patch — no surgery required

Two-Component System

📱 Reusable Probe

24-month lifespan with advanced ultrasound technology

🩹 Adhesive Patch

Replaced every 3 days for optimal contact and hygiene

The Problem

Heart Failure: A $70B Crisis

Heart failure is a major healthcare burden, with millions of patients and rising costs. Reactive care leads to repeated hospitalizations and mounting expense.

6.7M

Heart Failure Patients in the US

Expected to reach 10 million by 2030.

2–3

Average Hospitalization

Per year for high-risk patients.

$45K

Annual Healthcare Costs

Per patient, with hospitalizations driving most expenses.

⊗

No solution exists today for continuous, non-invasive cardiac monitoring.

Innovation

Patented Technology Platform

EchoWear's proprietary platform delivers superior performance, efficiency, and diagnostic accuracy for continuous cardiac monitoring.

🎯

Radar-Derived Imaging

A novel ultrasound formation technique adapted from radar technology, enabling compact wearable imaging.

🔋

Ultra-Low Power Operation

Breakthrough energy efficiency supports safe, continuous multi-day use on a single charge.

🛡️

Interference Resistant

Robust imaging stays reliable despite factors like the rib cage or patient movement.

🤖

Automated AI Measurements

Machine learning provides real-time automated analysis and removes operator variability.

ℹ️

U.S. Patent No. 11,918,418: Our core technology is protected by intellectual property, ensuring a competitive advantage in the medical device market.

Opportunity

Market Opportunity

The cardiac remote patient monitoring market is growing rapidly, and EchoWear is positioned to win in the high-acuity segment.

Total Market

$5.5B

Cardiac RPM market size by 2033

Growth Rate

13.2%

Compound annual growth rate through 2033

Initial TAM

500K

High-risk heart failure patients — our beachhead market

The Device

EchoWear: Real-Time 3D Ultrasound Platform

EchoWear delivers continuous, non-invasive 3D cardiac ultrasound monitoring for healthcare providers.

Real-Time 3D Visualization

Provides immediate 3D views of heart activity for clearer diagnostic insight.

Non-Invasive & Safe

Offers comfortable cardiac monitoring without invasive procedures.

Continuous Cardiac Data

Tracks critical pump function continuously to capture subtle changes over time.

User-Friendly Wearable Design

Designed for daily wear with a seamless, comfortable patient experience.

The People

Meet Our Team

Experienced across medical devices, cardiology, AI algorithms & business development.

Mati Shirizly

Co-founder, CEO/CTO

30 years in R&D, business development, and signal/image processing, with deep experience in ultrasound solutions.

Prof. Gerald Maurer

Co-founder, CMO

Former cardiology chair at the Medical University of Vienna and longtime leader in noninvasive cardiology at Cedars-Sinai and UCLA.

Conrad H. Smits

Business / Strategic Advisor

Former Executive Vice President at Royal Philips who led multiple healthcare divisions.

Prof. Jeroen Bax

Clinical Advisor

Director of Noninvasive Imaging at LUMC and former President of the European Society of Cardiology.

Our Board Members

Assaf Barnea

Chairman of the Board

Seasoned entrepreneur and venture professional who leads Sanara Ventures and advises global innovation efforts.

Eli Yered

CFO

Experienced CFO in corporate finance, strategy, accounting, and financial reporting, including at Sanara Ventures.

EchoWearTM